2018 Q2 Form 10-Q Financial Statement
#000114420418039198 Filed on July 23, 2018
Income Statement
| Concept | 2018 Q2 | 2017 Q2 | 2017 Q1 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Cost Of Revenue | |||
| YoY Change | |||
| Gross Profit | |||
| YoY Change | |||
| Gross Profit Margin | |||
| Selling, General & Admin | $1.610M | $640.0K | $830.0K |
| YoY Change | 151.56% | -22.89% | 0.0% |
| % of Gross Profit | |||
| Research & Development | $1.480M | $435.0K | $941.0K |
| YoY Change | 240.23% | 188.08% | -4.95% |
| % of Gross Profit | |||
| Depreciation & Amortization | $31.00K | $18.00K | $16.00K |
| YoY Change | 72.22% | -18.18% | 0.0% |
| % of Gross Profit | |||
| Operating Expenses | $3.090M | $435.0K | $941.0K |
| YoY Change | 610.34% | 188.08% | -48.01% |
| Operating Profit | -$3.087M | -$1.075M | -$1.770M |
| YoY Change | 187.16% | 9.36% | -2.32% |
| Interest Expense | |||
| YoY Change | |||
| % of Operating Profit | |||
| Other Income/Expense, Net | $0.00 | $40.00K | -$20.00K |
| YoY Change | -100.0% | 100.0% | -200.0% |
| Pretax Income | -$3.090M | -$1.040M | -$1.790M |
| YoY Change | 197.12% | 8.33% | 0.0% |
| Income Tax | |||
| % Of Pretax Income | |||
| Net Earnings | -$3.090M | -$1.040M | -$1.790M |
| YoY Change | 197.12% | 8.11% | 0.0% |
| Net Earnings / Revenue | |||
| Basic Earnings Per Share | |||
| Diluted Earnings Per Share | -$158.4K | -$55.50K | -$95.77K |
| COMMON SHARES | |||
| Basic Shares Outstanding | 18.74M shares | ||
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2018 Q2 | 2017 Q2 | 2017 Q1 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $17.44M | $6.720M | $8.350M |
| YoY Change | 159.52% | -41.46% | -35.52% |
| Cash & Equivalents | $2.262M | $5.784M | $604.0K |
| Short-Term Investments | $15.18M | $930.0K | $7.740M |
| Other Short-Term Assets | $1.160M | $230.0K | $180.0K |
| YoY Change | 404.35% | 228.57% | 125.0% |
| Inventory | |||
| Prepaid Expenses | $1.103M | ||
| Receivables | $960.0K | $740.0K | $200.0K |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $19.56M | $7.680M | $8.730M |
| YoY Change | 154.69% | -40.05% | -35.38% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $600.0K | $300.0K | $280.0K |
| YoY Change | 100.0% | -5.66% | -0.36% |
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $860.0K | $20.00K | $30.00K |
| YoY Change | 4200.0% | -94.13% | -90.13% |
| Total Long-Term Assets | $1.460M | $320.0K | $300.0K |
| YoY Change | 356.25% | -6.98% | -1.32% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $19.56M | $7.680M | $8.730M |
| Total Long-Term Assets | $1.460M | $320.0K | $300.0K |
| Total Assets | $21.02M | $8.000M | $9.030M |
| YoY Change | 162.75% | -39.18% | -34.63% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $4.180M | $230.0K | $360.0K |
| YoY Change | 1717.39% | -35.21% | 28.11% |
| Accrued Expenses | $1.470M | $114.0K | $90.00K |
| YoY Change | 1189.47% | -82.52% | -86.67% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | |||
| YoY Change | |||
| Total Short-Term Liabilities | $8.150M | $711.0K | $789.0K |
| YoY Change | 1046.27% | -44.54% | -36.47% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Other Long-Term Liabilities | |||
| YoY Change | |||
| Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $8.150M | $711.0K | $789.0K |
| Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
| Total Liabilities | $8.150M | $710.0K | $790.0K |
| YoY Change | 1047.89% | -44.53% | -36.29% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$77.95M | -$76.91M | |
| YoY Change | 6.93% | 6.92% | |
| Common Stock | $11.00K | $85.15M | |
| YoY Change | -99.99% | 774000.0% | |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $12.87M | $7.290M | $8.243M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $21.02M | $8.000M | $9.032M |
| YoY Change | 162.75% | -39.18% | -34.6% |
Cashflow Statement
| Concept | 2018 Q2 | 2017 Q2 | 2017 Q1 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$3.090M | -$1.040M | -$1.790M |
| YoY Change | 197.12% | 8.11% | 0.0% |
| Depreciation, Depletion And Amortization | $31.00K | $18.00K | $16.00K |
| YoY Change | 72.22% | -18.18% | 0.0% |
| Cash From Operating Activities | $55.00K | -$1.630M | -$1.640M |
| YoY Change | -103.37% | 15.6% | -44.97% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $215.0K | $32.00K | $0.00 |
| YoY Change | 571.88% | -45.76% | -100.0% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | -$12.82M | $6.810M | $1.700M |
| YoY Change | -288.25% | 3305.0% | -64.51% |
| Cash From Investing Activities | -$13.03M | $6.780M | $1.699M |
| YoY Change | -292.23% | 5115.38% | -64.38% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | $11.99M | $30.00K | $0.00 |
| YoY Change | 39880.0% | ||
| NET CHANGE | |||
| Cash From Operating Activities | $55.00K | -$1.630M | -1.640M |
| Cash From Investing Activities | -$13.03M | $6.780M | $1.699M |
| Cash From Financing Activities | $11.99M | $30.00K | $0.00 |
| Net Change In Cash | -$984.0K | $5.180M | $1.699M |
| YoY Change | -119.0% | -504.69% | -5.08% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | $55.00K | -$1.630M | -$1.640M |
| Capital Expenditures | $215.0K | $32.00K | $0.00 |
| Free Cash Flow | -$160.0K | -$1.662M | -$1.640M |
| YoY Change | -90.37% | 13.14% | -45.44% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2018Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
19505157 | shares |
| CY2018Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3087000 | USD |
| CY2017Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
435000 | USD |
| CY2017Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
640000 | USD |
| CY2017Q2 | bcli |
Financial Expenses Income Net
FinancialExpensesIncomeNet
|
-35000 | USD |
| CY2017Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1040000 | USD |
| CY2017Q2 | us-gaap |
Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
|
-0.06 | |
| us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
19277518 | shares | |
| us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1376000 | USD | |
| us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1469000 | USD | |
| bcli |
Financial Expenses Income Net
FinancialExpensesIncomeNet
|
-20000 | USD | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-2825000 | USD | |
| us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
18713575 | shares | |
| CY2016Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
9902000 | USD |
| CY2017 | us-gaap |
Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
|
62000 | USD |
| CY2017 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
554000 | USD |
| CY2017 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
209000 | USD |
| CY2017 | bcli |
Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
|
105000 | USD |
| CY2017 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4952000 | USD |
| us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
363000 | USD | |
| us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
25000 | USD | |
| us-gaap |
Depreciation
Depreciation
|
56000 | USD | |
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-2071000 | USD | |
| bcli |
Increase Decrease In Accounts Receivable And Prepaid Expenses
IncreaseDecreaseInAccountsReceivableAndPrepaidExpenses
|
-295000 | USD | |
| us-gaap |
Depreciation
Depreciation
|
34000 | USD | |
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-3272000 | USD | |
| us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
2758000 | USD | |
| us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
-118000 | USD | |
| bcli |
Increase Decrease In Deferred Grant Income
IncreaseDecreaseInDeferredGrantIncome
|
-740000 | USD | |
| bcli |
Increase Decrease In Deferred Grant Income
IncreaseDecreaseInDeferredGrantIncome
|
0 | USD | |
| CY2018Q2 | us-gaap |
Depreciation
Depreciation
|
31000 | USD |
| CY2018Q2 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
55000 | USD |
| CY2018Q2 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
136000 | USD |
| CY2017Q2 | us-gaap |
Depreciation
Depreciation
|
18000 | USD |
| CY2017Q2 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
57000 | USD |
| CY2017Q2 | us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
57000 | USD |
| CY2017Q2 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1630000 | USD |
| CY2017Q2 | bcli |
Increase Decrease In Accounts Receivable And Prepaid Expenses
IncreaseDecreaseInAccountsReceivableAndPrepaidExpenses
|
587000 | USD |
| CY2018Q2 | us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
921000 | USD |
| CY2017Q2 | us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
-135000 | USD |
| CY2018Q2 | bcli |
Increase Decrease In Deferred Grant Income
IncreaseDecreaseInDeferredGrantIncome
|
683000 | USD |
| CY2017Q2 | bcli |
Increase Decrease In Deferred Grant Income
IncreaseDecreaseInDeferredGrantIncome
|
0 | USD |
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
260000 | USD | |
| us-gaap |
Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
|
9904000 | USD | |
| bcli |
Investment In Lease Deposit
InvestmentInLeaseDeposit
|
5000 | USD | |
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-10169000 | USD | |
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
12019000 | USD | |
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
32000 | USD | |
| us-gaap |
Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
|
-8510000 | USD | |
| bcli |
Investment In Lease Deposit
InvestmentInLeaseDeposit
|
-1000 | USD | |
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
8479000 | USD | |
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
30000 | USD | |
| us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
5237000 | USD | |
| CY2016Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
547000 | USD |
| us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
25000 | USD | |
| us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
30000 | USD | |
| CY2018Q2 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
215000 | USD |
| CY2018Q2 | us-gaap |
Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
|
12818000 | USD |
| CY2018Q2 | bcli |
Investment In Lease Deposit
InvestmentInLeaseDeposit
|
0 | USD |
| CY2018Q2 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-13033000 | USD |
| CY2018Q2 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
11994000 | USD |
| CY2018Q2 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-984000 | USD |
| CY2017Q2 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
32000 | USD |
| CY2017Q2 | us-gaap |
Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
|
-6810000 | USD |
| CY2017Q2 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
6780000 | USD |
| CY2017Q2 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
30000 | USD |
| CY2017Q2 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
5180000 | USD |
| CY2017Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
604000 | USD |
| CY2018Q2 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
0 | USD |
| CY2017Q2 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
30000 | USD |
| us-gaap |
Maturity Of Time Deposits
MaturityOfTimeDeposits
|
P12M | ||
| CY2018Q2 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
1103000 | USD |
| CY2017Q3 | us-gaap |
Grants Receivable
GrantsReceivable
|
15912000 | USD |
| CY2017 | us-gaap |
Proceeds From Grantors
ProceedsFromGrantors
|
7050000 | USD |
| CY2017 | us-gaap |
Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
|
4425000 | USD |
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
363000 | USD | |
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
183000 | USD | |
| CY2018Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.00005 | |
| CY2017Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.00005 | |
| CY2018Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
| CY2018Q2 | us-gaap |
Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
|
827000 | USD |
| CY2017Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
1103000 | USD |
| CY2017Q4 | us-gaap |
Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
|
1378000 | USD |
| CY2017Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
| CY2018Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
20669528 | shares |
| CY2018Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
20669528 | shares |
| CY2017Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
18976169 | shares |
| CY2017Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
18976169 | shares |
| us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
11994000 | USD | |
| us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
USD | ||
| CY2018Q2 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
11994000 | USD |
| CY2017Q2 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
USD | |
| us-gaap |
Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
|
2740000 | USD | |
| CY2018Q2 | us-gaap |
Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
|
18200000 | USD |
| bcli |
Stock Issued During Periodvalueexercise And Reissuance Of Warrants
StockIssuedDuringPeriodvalueexerciseAndReissuanceOfWarrants
|
11994000 | USD | |
| bcli |
Validity Of Royalty Payment Not Covered By Valid Claim Or Orphan Drug Status
ValidityOfRoyaltyPaymentNotCoveredByValidClaimOrOrphanDrugStatus
|
P15Y | ||
| us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
59000000 | USD | |
| CY2017 | us-gaap |
Maturity Of Time Deposits
MaturityOfTimeDeposits
|
P12M | |
| us-gaap |
Proceeds From Grantors
ProceedsFromGrantors
|
9050000 | USD | |
| us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"> <tr> <td style="WIDTH: 28.35pt"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt">D.</div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt">Use of estimates</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -28.35pt; MARGIN: 0pt 0px 0pt 85.05pt; FONT: bold 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"><font style="FONT-WEIGHT: normal">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | ||
| CY2018Q2 | bcli |
Receipts On Account Of Shares
ReceiptsOnAccountOfShares
|
4391000 | USD |
| CY2017Q4 | bcli |
Receipts On Account Of Shares
ReceiptsOnAccountOfShares
|
0 | USD |
| CY2018Q2 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
899999 | shares |
| CY2018Q2 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
11994000 | USD |
